Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis

Objectives: With the development of new technologies capable of detecting low concentrations of Alzheimer’s disease (AD) relevant biomarkers, the idea of a blood-based diagnosis of AD is nearing reality. This study aims to consider the evidence of total and phosphorylated tau as blood-based biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Zabala-Findlay, Alex, Penny, Lewis K., Lofthouse, Richard A., Porter, Andrew J., Palliyil, Soumya, Harrington, Charles R., Wischik, Claude M., Arastoo, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136726/
https://www.ncbi.nlm.nih.gov/pubmed/37190093
http://dx.doi.org/10.3390/cells12081184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136726/
https://www.ncbi.nlm.nih.gov/pubmed/37190093
http://dx.doi.org/10.3390/cells12081184

Ejemplares similares